Testing the top two drug candidates -- 'letrozole' and 'irinotecan', both of which are cancer medications -- in a mouse model ...

Study finds two cancer drugs could slow Alzheimer's disease in mice, offering promise for reversing symptoms in humans.

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

Mouse studies identified the cancer drugs letrozole and irinotecan as a potential combination therapy for Alzheimer's disease ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...